Olema Pharmaceuticals, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $48.6M | $52.5M | $48.3M | $35.3M | $52.5M | $50.6M | $139.5M | $35.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $469.9M | $513.2M | $515.5M | $334.3M | $367.7M | $396.7M | $438.5M | $218.0M |
| Property, Plant & Equipment | $382.0K | $356.0K | $274.0K | $486.0K | $560.0K | $653.0K | $746.0K | $849.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $486.6M | $530.6M | $533.4M | $352.5M | $382.0M | $409.6M | $451.0M | $230.2M |
| Liabilities | ||||||||
| Accounts Payable | $1.7M | $3.7M | $9.3M | $3.5M | $934.0K | $151.0K | $4.5M | $2.7M |
| Total Current Liabilities | $53.0M | $47.2M | $51.8M | $41.7M | $33.2M | $26.1M | $41.8M | $30.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $56.0M | $50.2M | $54.9M | $45.0M | $36.8M | $26.2M | $42.0M | $31.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-713.8M | $-650.6M | $-597.6M | $-551.5M | $-509.3M | $-465.5M | $-435.1M | $-401.5M |
| Total Stockholders' Equity | $430.6M | $480.5M | $478.6M | $307.5M | $345.2M | $383.5M | $409.0M | $198.9M |